CINFSunday, August 19, 2007

8:25 AM-12:10 PM BCEC -- 252 A, Oral
Drug Reprofiling
Organizers:Alexander Tropsha
Christopher A. Lipinski
8:25 AMIntroductory Remarks
8:30 AMMining the receptorome: A powerful approach for predicting efficacies and side effects of repositioned medications
Bryan L. Roth
8:55 AMSide effect profile prediction: Computational tackling of big pharma's worst nightmare at an early stage
Josef Scheiber, Jeremy L. Jenkins, Andreas Bender, Steven Whitebread, Jacques Hamon, Laszlo Urban, Kamal Azzaoui, James H. Nettles, Meir Glick, John W. Davies
9:20 AMDevelopment of high-throughput repurposing technologies
Josep Prous Jr., David Aragones
9:45 AMUse of integrative pharmacology in drug repositioning
Thomas Barnes
10:10 AMIntermission
10:30 AMTranscriptional connectivity map for biomedical discovery
Justin Lamb
10:55 AMGAUDI: An integrated tool for navigating through the small molecule - target protein space
Jordi Mestres, Tudor I. Oprea
11:20 AMRelating protein pharmacology by ligand chemistry
MJ Keiser, Bryan L. Roth, BN Armburster, P Ernsberger, John J Irwin, Brian K. Shoichet
11:45 AMHypothesis-driven drug reprofiling based on a novel systems biology approach
Fredric S. Young

Drug Reprofiling -- Next Session

Symposium Grid -- Division of Chemical Information -- Session Listing

The 234th ACS National Meeting, Boston, MA, August 19-23, 2007